By Neil J Kanatt Feb 25 (Reuters) - TJX Cos forecast annual sales and profit below Wall Street estimates on Wednesday, ...
Nvidia was up 2% ahead of its earnings report, which is scheduled to be released after the bell along with results from ...
Metallus (MTUS) upgraded to Strong Buy with $32 target. MTUS is positioned for volume and pricing tailwinds as new production ...
U.S. stocks are drifting higher in the countdown to Wall Street’s main event. The S&P 500 rose 0.5% Wednesday ahead of a profit report from Nvidia, which is scheduled to arrive after trading ends for ...
Intel Corporation shares are consolidating after a long-term breakout, with buyers defending key support and positioning for ...
The crypto lender suspended client deposits and withdrawals earlier this month due to recent market and financial conditions.
A popular exchange-traded fund that tracks the Nasdaq-100 Index NDX and is known by its ticker symbol "QQQ" has posted a loss over the trailing 50-days - something the tech-heavy equities ETF seldom ...
The home improvement giant beat muted expectations despite a weak housing market and nervous American consumers, and offered ...
Gold and silver prices steadied as a firm US dollar capped gains. Market eyes US trade policy, Iran-US Geneva talks, and Fed rate outlook for further direction.
In January, MIAX completed the sale of 90% of MIAX Derivatives Exchange to a joint venture established by Robinhood Markets in partnership with Susquehanna International Group, retaining a 10% stake.
Immunome stock performance snapshot Immunome (IMNM) has drawn fresh attention after recent share price swings, with the stock up about 1.5% over the past day but showing a roughly 14% decline over the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results